RBC Bioscience Corporation (TPEX:6848)

RBC Bioscience Revenue

RBC Bioscience had revenue of 112.01M TWD in the half year ending December 31, 2025, with 34.10% growth. This brings the company's revenue in the last twelve months to 220.60M, up 9.29% year-over-year. In the year 2025, RBC Bioscience had annual revenue of 219.71M with 7.05% growth.

• Revenue (ttm): 220.60M
• Revenue Growth: +9.29%
• P/S Ratio: 1.26
• Revenue / Employee: 4.41M
• Employees: 50
• Market Cap: 276.91M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	219.71M	14.46M	7.05%
Dec 31, 2024	205.25M	32.78M	19.01%
Dec 31, 2023	172.47M	-1.42M	-0.82%
Dec 31, 2022	173.89M	-77.29M	-30.77%
Dec 31, 2021	251.18M	-323.98M	-56.33%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 19, 2026

Data Sources Report a data error